Slaying SARS-CoV-2 One (Single-domain) Antibody at a Time

Camelid-derived and synthetic single-domain antibodies (sdAbs) are emerging as potent weapons against the novel coronavirus, SARS-CoV-2. sdAbs are small, compact, thermostable immunoglobulin elements capable of binding targets with subnanomolar affinities. By leveraging the power of phage- and yeast...

Descripción completa

Detalles Bibliográficos
Autores principales: Czajka, Timothy F., Vance, David J., Mantis, Nicholas J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7744031/
https://www.ncbi.nlm.nih.gov/pubmed/33446406
http://dx.doi.org/10.1016/j.tim.2020.12.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7744031/
https://www.ncbi.nlm.nih.gov/pubmed/33446406
http://dx.doi.org/10.1016/j.tim.2020.12.006

Ejemplares similares